2519 |
How to Treat In-Stent Restenosis: DEB vs. DES |
Alaide Chieffo |
Apr. 20. 15 |
2518 |
What Can We Look Forward to from the Magnesium Scaffold? |
Ron Waksman |
Apr. 20. 15 |
2517 |
Use of Drug Coated Balloons in Coronary Intervention: Where No Stent Is the Best Stent. |
Paul JL Ong |
Apr. 20. 15 |
2516 |
Drug-coated Balloon: Established Indications and Beyond |
Paul JL Ong |
Apr. 20. 15 |
2515 |
New DES Lower DES Failure?: In-Stent Restenosis and Stent Thrombosis in New DES |
Imad Sheiban |
Apr. 20. 15 |
2514 |
Safety and Efficacy of an Ultrathin-strut SES with Bioabsorbable Polymer Coating |
Giulio G. Stefanini |
Apr. 20. 15 |
2513 |
Neoatherosclerosis in New DES: Insight from Intracoronary Imaging |
Soo-Jin Kang |
Apr. 20. 15 |
2512 |
Experience of BVS in Complex Lesions |
Corrado Tamburino |
Apr. 20. 15 |
2511 |
DES Failure: Pathologic Findings and Treatment |
Renu Virmani |
Apr. 20. 15 |
2510 |
SURTAVI: Transaortic Valve Replacement Compared to Surgical Aortic Valve Replacement in Medium-Risk Patients |
Patrick W. Serruys |
Apr. 20. 15 |